Condition
Stage 0 Breast Carcinoma
Total Trials
4
Recruiting
1
Active
1
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (2)
P 1 (1)
P 4 (1)
Trial Status
Completed3
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07042581Phase 4Recruiting
A Study of Revaree Plus in People With Breast Cancer
NCT02278965Phase 1CompletedPrimary
Metformin and Omega-3 Fatty Acids in Woman With a History of Early Stage Breast Cancer
NCT01688388Not ApplicableCompleted
Single Fraction Intraoperative Radiotherapy
NCT00225927Not ApplicableCompleted
Trial Comparing Radioactive Seed Localization to Standard Procedure for Non-palpable Breast Cancers
Showing all 4 trials